Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;16(6):e004181.
doi: 10.1161/CIRCGEN.123.004181. Epub 2023 Oct 10.

Cardiovascular Disease Knowledge Portal: A Community Resource for Cardiovascular Disease Research

Affiliations

Cardiovascular Disease Knowledge Portal: A Community Resource for Cardiovascular Disease Research

Maria C Costanzo et al. Circ Genom Precis Med. 2023 Dec.
No abstract available

Keywords: biomarkers; cardiovascular diseases; database; epigenomics; myocardial infarction; phenotype.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Lubitz is a full-time employee of Novartis Institutes of BioMedical Research as of July 18, 2022. Dr Lubitz was previously supported by National Institutes of Health (NIH) grants R01HL139731 and R01HL157635, and American Heart Association 18SFRN34250007. Dr Lubitz received sponsored research support from Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, Fitbit, Medtronic, Premier, and IBM and has consulted for Bristol Myers Squibb, Pfizer, Blackstone Life Sciences, and Invitae. Dr Ellinor receives sponsored research support from Bayer AG, IBM Research, Bristol Myers Squibb, and Pfizer; he has also served on advisory boards or consulted for Bayer AG, MyoKardia, and Novartis. Dr Thomas Lumbers receives sponsored research support from Pfizer. Dr Khera is an employee of Verve Therapeutics; has served as a scientific advisor to Amgen, Color Health, Foresite Labs, Illumina, Maze Pharmaceuticals, MedGenome, Navitor Pharmaceuticals, Novartis, Sanofi, Sarepta Therapeutics, Third Rock Therapeutics, and Veritas International; holds equity in Verve Therapeutics, Color Health, and Foresite Labs; and has received research funding from IBM Research. Dr Butterworth reports institutional grants outside of this work from AstraZeneca, Bayer, Biogen, BioMarin, Bioverativ, Novartis, Regeneron, and Sanofi.

Figures

Figure.
Figure.
Scientific questions that can be addressed using the CVDKP. A: The Phenotype page, illustrated for the “Atrial fibrillation” (AF) phenotype, illuminates the genetic architecture of a disease or trait by displaying (top to bottom) a Manhattan plot of bottom-line genetic associations accompanied by a table (not shown) of the top associations; a plot and table of common variant gene-level associations and a table of pathways enriched for the top genes associated with AF, both determined using the MAGMA algorithm (de Leeuw CA et al., PLoS Comput Biol. 2015; 11:e1004219); and a table of phenotypes whose genetic architecture is correlated with that of AF, as determined by cross-trait LD-Score regression (Finucane HK et al., Nat Genet. 2015; 47:1228). B: Top, the Region page near the MYO9B gene shows significant associations for coronary artery disease (CAD), total cholesterol, and diastolic blood pressure. Bottom, scores from the Human Genetic Evidence calculator on the Gene page, which takes into account variant impact, common variant associations, and rare variant associations to generate summaries of the evidence for involvement of a gene in a disease or trait, predict that MYO9B may have roles in CAD and traits that impact CAD risk. This gene has been experimentally shown to have a role in regulating vascular cell motility, supporting a role in CAD risk (Aragam K et al., Nat Genet. 2022; 54: 1803). C: Lists of predicted effector genes, curated from the literature, are available for multiple diseases and traits; the Gene page links to any effector lists on which that gene is represented. The MYO9B gene (see panel A) is included in 8 effector lists, for CAD, blood pressure, and lipid traits. Shown, part of the interactive table representing CAD effector gene predictions from the CARDIoGRAMplusC4D consortium (Aragam K et al., Nat Genet. 2022; 54:1803), which considered 8 types of evidence to predict the causal gene at each CAD-associated genetic locus. The table includes summary rows that are expandable (bottom) to show detailed evidence. D. The Variant Sifter displays genetic associations, credible sets, tissue-specific epigenomic annotations, and variant-gene links determined from chromatin conformation assays, as well as an interactive table (not shown) listing coordinates and parameters and linking to the source datasets. In this example, the LDL-associated variant rs2618566 near the RRBP1 gene is seen to have high posterior probability in LDL credible sets, to be located in a predicted enhancer region in HepG2 cells, and to be linked to the RRBP1 promoter in both adipose and liver tissue, recapitulating findings by Ramdas et al. (Am J Hum Genet. 2022;109:1366).

References

    1. McClellan M, Brown N, Califf RM, Warner JJ. Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. 2019;139:e44–e54. - PubMed
    1. Costanzo MC, von Grotthuss M, Massung J, Jang D, Caulkins L, Koesterer R, Gilbert C, Welch RP, Kudtarkar P, Hoang Q, et al. The Type 2 Diabetes Knowledge Portal: an open access genetic resource dedicated to type 2 diabetes and related traits. Cell Metabolism. 2023, 35:P695–710.E6. - PMC - PubMed
    1. Crawford KM, Gallego-Fabrega C, Kourkoulis C, Miyares L, Marini S, Flannick J, Burtt NP, von Grotthuss M, Alexander B, Costanzo MC, et al. Cerebrovascular Disease Knowledge Portal: An Open-Access Data Resource to Accelerate Genomic Discoveries in Stroke. Stroke. 2018; 49:470–475. - PMC - PubMed
    1. Dornbos P, Singh P, Jang D, Mahajan A, Biddinger SB, Rotter JI, McCarthy MI, Flannick J. Evaluating human genetic support for hypothesized metabolic disease genes. Cell Metabolism. 2022;34:661–666. - PMC - PubMed
    1. Khomtchouk BB, Nelson CS, Vand KA, Palmisano S, Grossman RL. HeartBioPortal2.0: new developments and updates for genetic ancestry and cardiometabolic quantitative traits in diverse human populations. Database (Oxford). 2020;baaa115. - PMC - PubMed

Publication types